Yoshihiro Ishikawa Selected Research

Glucose (Dextrose)

8/2004	Insulin resistance in skeletal muscles of caveolin-3-null mice.
10/2002	Diabetes is not a potent inducer of neuronal cell death in mouse sensory ganglia, but it enhances neurite regeneration in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihiro Ishikawa Research Topics

Disease

20	Heart Failure 01/2022 - 08/2003
19	Neoplasms (Cancer) 02/2024 - 08/2007
7	Cardiomyopathies (Cardiomyopathy) 01/2021 - 11/2004
7	Hyperthermia 01/2019 - 05/2012
6	Vascular Remodeling 03/2017 - 09/2007
6	Hypertrophy 05/2016 - 12/2002
5	Osteogenesis Imperfecta (Lobstein Disease) 12/2022 - 05/2010
5	Melanoma (Melanoma, Malignant) 07/2017 - 10/2009
5	Cardiomegaly (Heart Hypertrophy) 12/2014 - 12/2003
4	Hypoxia (Hypoxemia) 11/2023 - 01/2008
4	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 10/2023 - 06/2014
4	Abdominal Aortic Aneurysm 01/2020 - 01/2012
4	Reperfusion Injury 09/2014 - 01/2008
4	Ischemia 04/2014 - 08/2003
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/2009 - 12/2002
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2017
3	Fibrosis (Cirrhosis) 01/2020 - 04/2013
3	Neointima 06/2019 - 09/2007
3	Cardiac Arrhythmias (Arrythmia) 01/2019 - 01/2016
3	Hypertension (High Blood Pressure) 03/2017 - 01/2003
3	Heart Diseases (Heart Disease) 01/2017 - 03/2009
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2016 - 11/2004
3	Vascular Ring 07/2014 - 09/2009
2	Neoplasm Metastasis (Metastasis) 05/2024 - 10/2009
2	Lung Neoplasms (Lung Cancer) 01/2023 - 07/2019
2	Idiopathic Pulmonary Fibrosis 01/2022 - 01/2017
2	Adenocarcinoma of Lung 03/2021 - 12/2017
2	Aortic Rupture 01/2020 - 06/2014
2	Hearing Loss (Hearing Impairment) 01/2020 - 06/2014
2	Inflammation (Inflammations) 01/2020 - 10/2018
2	Mouth Neoplasms (Oral Cancer) 03/2018 - 05/2014
2	Septic Shock (Toxic Shock Syndrome) 01/2018 - 01/2017
2	Aortic Aneurysm (Aneurysm, Aortic) 03/2017 - 01/2012
2	Pathologic Constriction (Stenosis) 03/2017 - 01/2012
2	Tongue Neoplasms (Tongue Neoplasm) 01/2017 - 01/2016
2	Hypertrophy of Masticatory Muscles 05/2016 - 12/2014
2	Infarction (Infarctions) 09/2014 - 01/2008
2	Pain (Aches) 12/2013 - 01/2012
2	Congenital Heart Defects (Congenital Heart Defect) 01/2012 - 06/2010
2	Insulin Resistance 03/2010 - 08/2004
2	Bradycardia 02/2007 - 08/2003

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 12/2022 - 09/2007
12	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2018 - 01/2003
11	erythromycin propionate-N-acetylcysteinateIBA 01/2019 - 09/2007
8	CatecholaminesIBA 01/2018 - 10/2007
6	mu-oxo N,N'- bis(salicylidene)ethylenediamine ironIBA 01/2019 - 03/2015
6	Isoproterenol (Isoprenaline)FDA LinkGeneric 12/2014 - 08/2003
6	Caveolin 3IBA 09/2014 - 12/2002
5	CollagenIBA 10/2023 - 01/2017
5	IronIBA 03/2018 - 03/2015
5	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 03/2018 - 03/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2019
4	Messenger RNA (mRNA)IBA 01/2020 - 04/2006
4	CytokinesIBA 01/2020 - 01/2012
4	Adrenergic Agents (Adrenergic Drugs)IBA 01/2015 - 11/2004
4	Protein Isoforms (Isoforms)IBA 12/2014 - 01/2003
4	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 07/2014 - 08/2003
4	Prostaglandins EIBA 01/2012 - 11/2006
3	FKBP22IBA 10/2023 - 06/2014
3	Tacrolimus Binding Proteins (FKBP)IBA 10/2023 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2012
3	Myosin Heavy Chains (Myosin Heavy Chain)IBA 07/2021 - 12/2014
3	Vidarabine (Vira-A)FDA Link 01/2018 - 06/2012
3	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 12/2014 - 08/2007
3	Hyaluronic Acid (Hyaluronan)IBA 01/2012 - 09/2007
3	CaveolinsIBA 03/2010 - 12/2002
3	beta Adrenergic ReceptorsIBA 02/2009 - 08/2003
2	CalciumIBA 09/2023 - 01/2022
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 03/2018
2	Collagen Type I (Type I Collagen)IBA 01/2021 - 05/2010
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019 - 03/2015
2	disalicylaldehyde ethylenediamine (salen)IBA 08/2017 - 03/2015
2	MetalsIBA 08/2017 - 03/2015
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 05/2016 - 12/2014
2	Histone Deacetylases (Histone Deacetylase)IBA 05/2016 - 12/2014
2	Calcium-Calmodulin-Dependent Protein KinasesIBA 05/2016 - 12/2014
2	Cyclic AMP (AMP, Cyclic)IBA 05/2016 - 12/2014
2	ClenbuterolIBA 05/2016 - 12/2014
2	ferric oxide (iron oxide)IBA 01/2016 - 05/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2015 - 05/2012
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2015 - 11/2004
2	TroponinIBA 09/2014 - 01/2008
2	Angiotensin IIIBA 09/2014 - 02/2009
2	cyclophilin BIBA 06/2014 - 06/2012
2	Anesthetics (Anesthetic Agents)IBA 04/2014 - 01/2008
2	GTP-Binding Proteins (G-Protein)IBA 01/2014 - 11/2009
2	Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA 01/2014 - 05/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 05/2011
2	Connexin 43 (Connexin43)IBA 01/2014 - 11/2009
2	Sirtuin 1IBA 07/2013 - 04/2013
2	Insulin (Novolin)FDA Link 03/2010 - 08/2004
2	Vasodilator Agents (Vasodilators)IBA 02/2009 - 11/2006
2	ColforsinIBA 09/2006 - 08/2003
2	Glucose (Dextrose)FDA LinkGeneric 08/2004 - 10/2002
1	STO 609IBA 05/2024
1	DesminIBA 02/2024

Therapy/Procedure

18	Therapeutics 01/2023 - 10/2007
11	Drug Therapy (Chemotherapy) 01/2019 - 08/2007
2	Adjuvant Chemotherapy 02/2024 - 07/2019
2	Induced Hyperthermia (Thermotherapy) 01/2016 - 05/2014